Pre-treatment immune biomarkers of pembrolizumab efficacy in patients with glioblastoma treated with standard of care. Therapeutic insights for the aggressive subset of high-grade gliomas (HGG) driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results